Research study Program year 2025 Source: CMS Open Payments

A Phase 3 Randomized, Open-Label (Sponsor-Blind), Active-Controlled, P

Research payments

$36,284,393

7,455 payments

Through program year 2025, $36,284,393 in research payments was reported against A Phase 3 Randomized, Open-Label (Sponsor-Blind), Active-Controlled, P, across 7,455 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$882	2
2024	Research	$86,564	1
2023	Research	$692,047	78
2022	Research	$4,149,268	1,120
2021	Research	$7,076,495	1,490
2020	Research	$10,824,374	2,574
2019	Research	$13,454,761	2,190

Breakdown

Who paid Research payments · program years 2019–2025

GlaxoSmithKline, LLC. $36,284,393 7,455 payments

Who received the money Research payments · program years 2019–2025

Davita Clinical Research Organisation paid for research $11,645,865 3,014 payments
Fresenius Managment Services INC Organisation paid for research $11,293,798 1,358 payments
Fresenius Management Services Organisation paid for research $1,190,701 321 payments
Elixia LLC Organisation paid for research $773,060 47 payments
Biolab Research LLC Organisation paid for research $623,277 218 payments
Clinical Research Connections Organisation paid for research $609,643 193 payments
Liberty Research Organisation paid for research $556,797 156 payments
Kidney Care Associates Organisation paid for research $528,738 15 payments
Southeastern Clinical Research Institute LLC Organisation paid for research $476,522 29 payments
Clinical Advancement Center Organisation paid for research $392,937 104 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.